Cargando…

Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression

BACKGROUND: Disease-modifying treatments for Huntington’s disease (HD) are entering clinical trials: there is a pressing need for objective outcome measures of disease progression. Our previous work showed an association between 2 novel, objective cognitive tasks and apathy - a core feature of disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hare, Emily, Bachoud-Lévi, Anne-Catherine, Reilmann, Ralf, Craufurd, David, Busse, Monica, Rosser, Anne, McLauchlan, Duncan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673112/ https://www.ncbi.nlm.nih.gov/pubmed/36405870 http://dx.doi.org/10.1016/j.prdoa.2022.100168

Ejemplares similares

Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease
por: McLauchlan, Duncan James, et al.
Publicado: (2022)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT)
por: Lunven, Marine, et al.
Publicado: (2021)

A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington’s disease
por: Lunven, Marine, et al.
Publicado: (2023)

Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Objectively characterizing Huntington’s disease using a novel upper limb dexterity test
por: Woodgate, Samuel, et al.
Publicado: (2021)

Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington’s disease
por: McLauchlan, Duncan James, et al.
Publicado: (2022)

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward
por: Bachoud‐Lévi, Anne‐Catherine, et al.
Publicado: (2020)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease
por: Morris, Lee‐Anne, et al.
Publicado: (2022)

The societal cost of Huntington's disease: are we underestimating the burden?
por: Jones, C., et al.
Publicado: (2016)

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
por: Baake, Verena, et al.
Publicado: (2018)

Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)

Awareness of Memory Deficits in Early Stage Huntington's Disease
por: Cleret de Langavant, Laurent, et al.
Publicado: (2013)

Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
por: Reilmann, Ralf
Publicado: (2013)

The specific role of the striatum in interval timing: The Huntington’s disease model
por: Lemoine, Laurie, et al.
Publicado: (2021)

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders
por: Anderson, Karen E., et al.
Publicado: (2018)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington’s disease
por: Nair, Akshay, et al.
Publicado: (2021)

How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
por: Schramm, Catherine, et al.
Publicado: (2015)

Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's Disease
por: Krystkowiak, Pierre, et al.
Publicado: (2007)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Utilisation of Healthcare and Associated Services in Huntington’s disease: a data mining study
por: Busse, Monica, et al.
Publicado: (2011)

Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study
por: Jacobs, M., et al.
Publicado: (2016)

Altered cerebrovascular response to acute exercise in patients with Huntington’s disease
por: Steventon, Jessica J, et al.
Publicado: (2020)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells
por: Bamford, Connor G.G., et al.
Publicado: (2020)

Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease
por: Lemercier, Pablo, et al.
Publicado: (2022)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Obsessive-Compulsive and Perseverative Behaviors in Huntington’s Disease
por: Oosterloo, Mayke, et al.
Publicado: (2019)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes
por: Mangin, Jean-Francois, et al.
Publicado: (2020)

HD-DRUM, a Tablet-Based Drumming Training App Intervention for People With Huntington Disease: App Development Study
por: Metzler-Baddeley, Claudia, et al.
Publicado: (2023)

Predicting clinical scores in Huntington’s disease: a lightweight speech test
por: Riad, Rachid, et al.
Publicado: (2022)

Huntington's Disease Gene Hunters: An Expanding Tale
por: Rosser, Anne E., et al.
Publicado: (2021)

Using Actiwatch to monitor circadian rhythm disturbance in Huntington’ disease: A cautionary note
por: Townhill, Jenny, et al.
Publicado: (2016)

Gait variability as digital biomarker of disease severity in Huntington’s disease
por: Gaßner, Heiko, et al.
Publicado: (2020)

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
por: De Waele, Ségolène, et al.
Publicado: (2022)

Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease
por: Kandasamy, Mahesh, et al.
Publicado: (2011)

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69u23da1qrp6f2e6oh292tfmqr